N,N-dimethylformamide: Evidence of carcinogenicity from national representative cohort study in South Korea

Jin Ha Yoon, Cheol In Yoo, Yeon Soon Ahn

Research output: Contribution to journalArticle

Abstract

Objective There is limited epidemiological evidence of carcinogenicity on exposure of N,N-dimethylformamide (DMF). This study aimed to identify the possible association between cancer mortality and DMF exposure. Methods A cohort of 11 953 workers exposed to DMF between 1 January 2000 and 31 December 2004 was studied. A urinary metabolite of DMF, N-methylformamide level (UNMFL), was used for exposure assessment. This cohort was matched with the mortality data of the Korean National Statistical Office and followed up for cancer mortality between 2000 and 2011. Standardized mortality ratios (SMR) of the DMF-exposed workers with reference to Korean men were calculated. Adjusted hazard ratios (HRadj also controlling for age, other carcinogen exposure including hepatitis B and C) were calculated for the workers categorized in three exposure groups with reference to workers with no exposure. Results The HRadj of overall cancer mortality were significantly increased in workers with 7.5-<15 mg/L [HRadj 2.72, 95% confidence interval (CI) 1.09-6.81] and =15 mg/L (HRadj 2.41, 95% CI 1.03-5.66) compared with non-exposed workers. Hepatocellular carcinoma mortality (HRadj 3.73, 95% CI 1.05-13.24) of workers with =15 mg/L and lung cancer mortality (HRadj 14.36, 95% CI 1.41-146.86) in workers with 7.5-<15 mg/L were significantly increased. Conclusions Workers with high DMF exposure showed increased mortalities for overall, liver, and lung cancer. Our results suggest that DMF causes cancer, especially hepatocellular carcinoma, which is in agreement with earlier studies on liver cancer in animal experiments.

Original languageEnglish
Pages (from-to)396-401
Number of pages6
JournalScandinavian Journal of Work, Environment and Health
Volume45
Issue number4
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Dimethylformamide
Republic of Korea
Cohort Studies
Mortality
Confidence Intervals
methylformamide
Liver Neoplasms
Hepatocellular Carcinoma
Lung Neoplasms
Neoplasms
Hepatitis C
Hepatitis B
Carcinogens

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

@article{80cdecf3907347758ead8d4cc2575497,
title = "N,N-dimethylformamide: Evidence of carcinogenicity from national representative cohort study in South Korea",
abstract = "Objective There is limited epidemiological evidence of carcinogenicity on exposure of N,N-dimethylformamide (DMF). This study aimed to identify the possible association between cancer mortality and DMF exposure. Methods A cohort of 11 953 workers exposed to DMF between 1 January 2000 and 31 December 2004 was studied. A urinary metabolite of DMF, N-methylformamide level (UNMFL), was used for exposure assessment. This cohort was matched with the mortality data of the Korean National Statistical Office and followed up for cancer mortality between 2000 and 2011. Standardized mortality ratios (SMR) of the DMF-exposed workers with reference to Korean men were calculated. Adjusted hazard ratios (HRadj also controlling for age, other carcinogen exposure including hepatitis B and C) were calculated for the workers categorized in three exposure groups with reference to workers with no exposure. Results The HRadj of overall cancer mortality were significantly increased in workers with 7.5-<15 mg/L [HRadj 2.72, 95{\%} confidence interval (CI) 1.09-6.81] and =15 mg/L (HRadj 2.41, 95{\%} CI 1.03-5.66) compared with non-exposed workers. Hepatocellular carcinoma mortality (HRadj 3.73, 95{\%} CI 1.05-13.24) of workers with =15 mg/L and lung cancer mortality (HRadj 14.36, 95{\%} CI 1.41-146.86) in workers with 7.5-<15 mg/L were significantly increased. Conclusions Workers with high DMF exposure showed increased mortalities for overall, liver, and lung cancer. Our results suggest that DMF causes cancer, especially hepatocellular carcinoma, which is in agreement with earlier studies on liver cancer in animal experiments.",
author = "Yoon, {Jin Ha} and Yoo, {Cheol In} and Ahn, {Yeon Soon}",
year = "2019",
month = "1",
day = "1",
doi = "10.5271/sjweh.3802",
language = "English",
volume = "45",
pages = "396--401",
journal = "Scandinavian Journal of Work, Environment and Health",
issn = "0355-3140",
publisher = "Finnish Institute of Occupational Health",
number = "4",

}

N,N-dimethylformamide : Evidence of carcinogenicity from national representative cohort study in South Korea. / Yoon, Jin Ha; Yoo, Cheol In; Ahn, Yeon Soon.

In: Scandinavian Journal of Work, Environment and Health, Vol. 45, No. 4, 01.01.2019, p. 396-401.

Research output: Contribution to journalArticle

TY - JOUR

T1 - N,N-dimethylformamide

T2 - Evidence of carcinogenicity from national representative cohort study in South Korea

AU - Yoon, Jin Ha

AU - Yoo, Cheol In

AU - Ahn, Yeon Soon

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective There is limited epidemiological evidence of carcinogenicity on exposure of N,N-dimethylformamide (DMF). This study aimed to identify the possible association between cancer mortality and DMF exposure. Methods A cohort of 11 953 workers exposed to DMF between 1 January 2000 and 31 December 2004 was studied. A urinary metabolite of DMF, N-methylformamide level (UNMFL), was used for exposure assessment. This cohort was matched with the mortality data of the Korean National Statistical Office and followed up for cancer mortality between 2000 and 2011. Standardized mortality ratios (SMR) of the DMF-exposed workers with reference to Korean men were calculated. Adjusted hazard ratios (HRadj also controlling for age, other carcinogen exposure including hepatitis B and C) were calculated for the workers categorized in three exposure groups with reference to workers with no exposure. Results The HRadj of overall cancer mortality were significantly increased in workers with 7.5-<15 mg/L [HRadj 2.72, 95% confidence interval (CI) 1.09-6.81] and =15 mg/L (HRadj 2.41, 95% CI 1.03-5.66) compared with non-exposed workers. Hepatocellular carcinoma mortality (HRadj 3.73, 95% CI 1.05-13.24) of workers with =15 mg/L and lung cancer mortality (HRadj 14.36, 95% CI 1.41-146.86) in workers with 7.5-<15 mg/L were significantly increased. Conclusions Workers with high DMF exposure showed increased mortalities for overall, liver, and lung cancer. Our results suggest that DMF causes cancer, especially hepatocellular carcinoma, which is in agreement with earlier studies on liver cancer in animal experiments.

AB - Objective There is limited epidemiological evidence of carcinogenicity on exposure of N,N-dimethylformamide (DMF). This study aimed to identify the possible association between cancer mortality and DMF exposure. Methods A cohort of 11 953 workers exposed to DMF between 1 January 2000 and 31 December 2004 was studied. A urinary metabolite of DMF, N-methylformamide level (UNMFL), was used for exposure assessment. This cohort was matched with the mortality data of the Korean National Statistical Office and followed up for cancer mortality between 2000 and 2011. Standardized mortality ratios (SMR) of the DMF-exposed workers with reference to Korean men were calculated. Adjusted hazard ratios (HRadj also controlling for age, other carcinogen exposure including hepatitis B and C) were calculated for the workers categorized in three exposure groups with reference to workers with no exposure. Results The HRadj of overall cancer mortality were significantly increased in workers with 7.5-<15 mg/L [HRadj 2.72, 95% confidence interval (CI) 1.09-6.81] and =15 mg/L (HRadj 2.41, 95% CI 1.03-5.66) compared with non-exposed workers. Hepatocellular carcinoma mortality (HRadj 3.73, 95% CI 1.05-13.24) of workers with =15 mg/L and lung cancer mortality (HRadj 14.36, 95% CI 1.41-146.86) in workers with 7.5-<15 mg/L were significantly increased. Conclusions Workers with high DMF exposure showed increased mortalities for overall, liver, and lung cancer. Our results suggest that DMF causes cancer, especially hepatocellular carcinoma, which is in agreement with earlier studies on liver cancer in animal experiments.

UR - http://www.scopus.com/inward/record.url?scp=85069235187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069235187&partnerID=8YFLogxK

U2 - 10.5271/sjweh.3802

DO - 10.5271/sjweh.3802

M3 - Article

C2 - 30904927

AN - SCOPUS:85069235187

VL - 45

SP - 396

EP - 401

JO - Scandinavian Journal of Work, Environment and Health

JF - Scandinavian Journal of Work, Environment and Health

SN - 0355-3140

IS - 4

ER -